Doctor profile · Federal record
Dr. Michelle Liang, M.D.
Ophthalmology Physician (CMS: Ophthalmology) · Internal Medicine Physician · Boston, MA
- NPI 1437483310
- Accepts Medicare
- 17 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
800 Washington St, Box 450
Boston, MA 021111552
(617) 636-4600
Credentials & registration
- NPI registered
- September 2009 — 17 yrs on file
- Profile last updated
- July 16, 2013
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207W00000X — NUCC code
- State licenses (2)
- Massachusetts #245785 · Massachusetts #241495
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1437483310. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
30,954
Distinct HCPCS
10
Medicare allowed
$2,639,073
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 23,589 | 86 | $36 | |
92134 |
Imaging of retina | 2,231 | 936 | $43 | |
J0178 |
Injection, aflibercept, 1 mg | 1,486 | 223 | $860 | |
67028 |
Injection of drug into eye | 1,264 | 298 | $130 | |
92014 |
Established patient complete exam of visual system | 1,074 | 874 | $136 | |
92134 |
Imaging of retina | 315 | 165 | $27 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 271 | 178 | $95 | |
92014 |
Established patient complete exam of visual system | 164 | 132 | $82 | |
J9035 |
Injection, bevacizumab, 10 mg | 143 | 65 | $70 | |
67028 |
Injection of drug into eye | 134 | 51 | $101 |
In context: peer comparison
Among 89 peers in this city , average services per provider: 193. This provider delivers 160× the peer median.Open Payments
Industry payments received
All-time total
$836
Transactions
26
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Genentech USA, Inc. | 7 | $281.15 | |
| Regeneron Healthcare Solutions, Inc. | 7 | $179.31 | |
| Regeneron Pharmaceuticals, Inc. | 1 | $136.31 | |
| Alimera Sciences, Inc. | 7 | $132.19 | |
| Astellas Pharma US Inc | 2 | $51.88 | |
| Coherus Biosciences Inc. | 1 | $28.14 | |
| ABBVIE INC. | 1 | $27.15 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
185
Patients
57
Total drug cost
$15,373
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketorolac Tromethamine | Generic | 58 | 27 | $2,008 |
| Prednisolone Acetate | Generic | 45 | 30 | $3,451 |
| Bromfenac Sodium | Generic | 28 | 0 | $6,829 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 25 | 0 | $498 |
| Difluprednate | Generic | 16 | 0 | $1,233 |
| Timolol Maleate | Generic | 13 | 0 | $1,354 |
Hospital affiliations
Frequently asked questions
What is Dr. Michelle Liang's medical specialty?
Dr. Michelle Liang practices Ophthalmology Physician in Boston, MA.
Where does Dr. Michelle Liang practice?
Dr. Michelle Liang practices at 800 Washington St, Boston, MA 021111552. Office phone: 6176364600.
What is Dr. Michelle Liang's NPI?
Dr. Michelle Liang's National Provider Identifier (NPI) is 1437483310, issued by NPPES.
Does Dr. Michelle Liang accept Medicare assignment?
Yes. Dr. Michelle Liang accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michelle Liang commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Imaging of retina (HCPCS 92134); Injection, aflibercept, 1 mg (HCPCS J0178). Source: CMS Medicare Physician & Other Practitioners file.